MoonLake Immunotherapeutics (MLTX) Minority Interest (2022 - 2025)
MoonLake Immunotherapeutics (MLTX) posted quarterly Minority Interest of $2.3 million for Q3 2025, down 68.73% year-over-year from $7.3 million in Q3 2024, and down 45.76% quarter-over-quarter from $4.2 million in Q2 2025.
MoonLake Immunotherapeutics (MLTX) Minority Interest (2022 - 2025) Analysis & Trends
MoonLake Immunotherapeutics' Minority Interest history runs 4 years deep, the most recent figure standing at $2.3 million for Q3 2025.
- In Q3 2025, Minority Interest fell 68.73% year-over-year to $2.3 million; the TTM figure through Sep 2025 stood at $2.3 million (down 68.73% YoY), while the FY2024 annual figure was $6.6 million, down 63.14% from the prior year.
- Minority Interest for Q3 2025 stood at $2.3 million, down from $4.2 million in the prior quarter.
- The five-year high for Minority Interest was $64.7 million in Q3 2023, with the low at $2.3 million in Q3 2025.
- The 4-year median for Minority Interest is $9.6 million (2024), against an average of $16.6 million.
- The sharpest annual moves came in 2023 and 2024: Minority Interest jumped 137.2% in 2023, then sank 88.71% in 2024.
- MoonLake Immunotherapeutics' Minority Interest stood at $19.9 million in 2022, then fell by 10.33% to $17.8 million in 2023, then slumped by 63.14% to $6.6 million in 2024, then plunged by 65.2% to $2.3 million in 2025.
- Business Quant data shows MLTX's Minority Interest at $2.3 million in Q3 2025, $4.2 million in Q2 2025, and $5.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | MoonLake Immunotherapeutics | 1.40 Bn | 864.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 4.21 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | 6.57 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Jun 30, 2024 | 9.37 Mn |
| Mar 31, 2024 | 9.83 Mn |
| Dec 31, 2023 | 17.82 Mn |
| Sep 30, 2023 | 64.71 Mn |
| Jun 30, 2023 | 9.31 Mn |
| Mar 31, 2023 | 17.11 Mn |
| Dec 31, 2022 | 19.87 Mn |
| Sep 30, 2022 | 27.28 Mn |
| Jun 30, 2022 | 31.04 Mn |